Financials

Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-0.26
Price to sales ratio
0.22

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
4569
RVP
Retractable Technologies, Inc. Common Stock
0.66 USD-2.94%-2.94%-9.59%-4.43%19.76 M USD
4635
ZJYL
JIN MEDICAL INTERNATIONAL LTD. - Class A Ordinary Shares
2.06 USD+7.85%+3.00%+7.85%+216.92%16.12 M USD
4796
FEMY
Femasys Inc. - Common Stock
2.86 USD-1.72%-20.56%-34.40%+271.43%8.64 M USD
4845
MLSS
Milestone Scientific, Inc. Common Stock
0.40 USD+2.56%+2.56%+21.21%-34.43%7.05 M USD

Frequently asked questions about Bionano Genomics, Inc. - Common Stock

What is the Bionano Genomics, Inc. - Common Stock stock price today?

The current price of Bionano Genomics, Inc. - Common Stock (BNGO) is 1.07. Over the past 24 hours, the stock has changed by +0.94%. Follow the BNGO chart for real-time price dynamics.

What is the stock ticker of Bionano Genomics, Inc. - Common Stock?

Bionano Genomics, Inc. - Common Stock trades under the ticker BNGO. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Bionano Genomics, Inc. - Common Stock stock going up?

BNGO has changed by -4.46% over the last week, -8.55% over the last month, and -6.96% over the last year. Review the chart to see whether the current move is part of a broader trend.

What is the market capitalization of Bionano Genomics, Inc. - Common Stock?

Bionano Genomics, Inc. - Common Stock currently has a market capitalization of 12.28 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.

What were Bionano Genomics, Inc. - Common Stock earnings last quarter?

Last quarter, Bionano Genomics, Inc. - Common Stock reported earnings of -0.76 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.

What was Bionano Genomics, Inc. - Common Stock revenue for the last quarter?

Bionano Genomics, Inc. - Common Stock reported quarterly revenue of 6.69 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.

What was Bionano Genomics, Inc. - Common Stock net income for the last quarter?

Bionano Genomics, Inc. - Common Stock reported net income of -8.3 M for the last quarter. The previous quarter showed -7.93 M, which means net income changed by -4.66%.

How many employees does Bionano Genomics, Inc. - Common Stock have?

As of the latest available data, Bionano Genomics, Inc. - Common Stock has 97 employees. Workforce size can provide additional context about the company's scale and operations.

What is Bionano Genomics, Inc. - Common Stock EBITDA?

Bionano Genomics, Inc. - Common Stock EBITDA is -2.15 M, and its EBITDA margin is -32.18%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy Bionano Genomics, Inc. - Common Stock stock?

You can buy Bionano Genomics, Inc. - Common Stock (BNGO) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Bionano Genomics, Inc. - Common Stock stock?

Investing in Bionano Genomics, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the BNGO chart and related analysis on metatrader.com as part of your research.

News